Hepion Pharmaceuticals
HEPA
#10702
Rank
C$0.88 M
Marketcap
C$0.07657
Share price
-3.51%
Change (1 day)
-88.67%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -C$6.68 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$21.65 Million, an increase over its 2023 earnings that were of -C$68.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.68 Million-69.15%
2024 -C$21.65 Million-68.5%
2023 -C$68.74 Million9.74%
2022 -C$62.64 Million37.49%
2021 -C$45.56 Million61.27%
2020 -C$28.25 Million174.55%
2019 -C$10.29 Million-31.28%
2018 -C$14.98 Million
2016 -C$29.72 Million6.03%
2015 -C$28.03 Million265%
2014 -C$7.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 3,034.96%๐Ÿ‡บ๐Ÿ‡ธ USA